Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This new systematic review and meta-analysis of randomised controlled trials assesses the effects of statins given alone, without concomitant antidepressant treatment, in people with depressive symptoms, but who do not have a formal diagnosis of a depressive disorder.

Half of statins tablets pill in female patient hand and white blister pack of them for light resistance packaging on white background

Statins are among the most prescribed medications worldwide, useful for preventing and treating heart and metabolic diseases. However, they also have anti-inflammatory effects, which make them interesting candidates for the treatment of depression, as this mental disorder has been linked to excessive inflammation. 

In this new study, The effects of statin monotherapy on depressive symptoms: A systematic review and meta-analysis, researchers pooled data from fourteen randomised controlled trials, which compared a statin given alone against placebo (a "dummy tablet"). A total of 2,712 people who were affected by depressive symptoms were involved in these trials. In this analysis, however, statins did not seem to make any difference in terms of improving or indeed worsening depressive symptoms.

A previous study, Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials, had shown promising evidence that statins, given along with antidepressants, may help in reducing depressive symptoms in patients who had been formally diagnosed with depression. However, it was still unclear whether statins could improve depressive symptoms regardless of a concurrent use of antidepressant medications.

Taken together, these findings suggest that statins do not decrease milder depressive symptoms on their own. However, statins plus antidepressants, compared to an antidepressant alone, appear to improve depression in patients who are most affected by it. 

Dr Riccardo De Giorgi, study author and Wellcome Trust Doctoral Training Fellow, University of Oxford, said:


'Our "null findings" are important because they suggest that statins, some very commonly prescribed drugs, do not change mood in the general population – in other words, they can be considered quite safe. According to our previous study, statins might improve depression in people diagnosed with this disorder, but only when given in addition to an antidepressant. Larger studies are needed to confirm the latest evidence, but overall, our results are significant because they suggest that future clinical trials should focus on this add-on use of statins and antidepressants, compared to statins alone, for the treatment of depression.'

Read the full study, The effects of statin monotherapy on depressive symptoms: A systematic review and meta-analysis, published in Journal of Affective Disorders.

Similar stories

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.

Testing for hearing loss could 'reduce dementia risk' later in life

Research by Sarah Bauermeister of Dementias Platform UK into hearing loss and its impacts on the progress of dementia in later life has featured in extensive media coverage of a Brain Health Check-In tool created by Alzheimer's Research UK.

Factors influencing cognitive development - new longitudinal study

Data comes from more than 2,600 individuals from four different countries and looks at links between factors like childhood stature, IQ and schooling.

Raised intracellular chloride levels underlie the effects of tiredness in cortex

A new study, co-authored by Professor Vladyslav Vyazovskiy, published in Nature Neuroscience, has revealed that intracellular chloride levels within cortical pyramidal neurons reflect sleep–wake history.

Updating the circuit maps of the sympathetic neural network

A new review from Professor Ana Domingos’ lab and colleagues offers a fresh modern viewpoint on sympathetic neurons and their relation to immune cells and obesity.

Many adolescents game a lot without negative effects on their wellbeing

Although many school-age adolescents are spending considerable time gaming, it is not having a negative impact on their wellbeing.